Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Three Kennedy Trust for Rheumatology Research (KTRR) Fellows at the Kennedy Institute were recently awarded prestigious funding awards, highlighting the success of the KTRR programme in supporting outstanding investigators launch their independent research career.

The KTRR Senior Research Fellowship programme creates a platform for early stage scientists to launch an independent research career; it has also enabled the Kennedy Institute to recruit bright young investigators from across the globe. 

“The KTRR provided a great opportunity for the Institute to recruit the best and brightest after the move to Oxford.” Says Professor Michael Dustin, Director of Research of the Kennedy Institute. “We are all excited by their progress in establishing their research programs and development as independent scientists.”

The five-year fellowships provide awardees with a generous funding package and strong mentorship, embedded within the institute’s outstanding research environment. 

The first of these fellowships was awarded in 2013 to Dr Tal Arnon, who has subsequently received a Wellcome Trust Investigator award in 2014.

Three more Senior Research Fellowships were awarded in 2016, to Dr Jelena Bezbradica Mirkovic, Dr Anjali Kusumbe, and Dr Audrey Gerard.

Dr Kusumbe received an MRC Career Development Fellowship in 2017 and earlier this year Dr Gerard won a BBSRC New Investigator Grant.

More recently, Dr Jelena Bezbradica Mirkovic won an MRC New Investigator Research Grant to study the biology of FAM26F protein in myeloid cells.

She says: “We are grateful to the Kennedy Trust for their support in establishing our independent research programmes. My group is investigating how innate immune cells, such as macrophages and dendritic cells, integrate tissue-derived inflammatory signals to initiate an appropriate effector response to infection or to sterile injury. The MRC New Investigator Grant is an exciting opportunity to investigate what role a poorly characterized protein, FAM26F, plays in the inflammatory process.”

 

Similar stories

Fiona Powrie honoured by British Society for Immunology

Fiona Powrie was one of four researchers from the University of Oxford recognised for their outstanding contributions to immunology with Honorary Lifetime Membership of the British Society for Immunology.

The Kennedy Institute scoops sustainability award

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

A drug being trialled to treat cancer, could be the key to reducing gut inflammation

Published in Nature Communications, a new study reveals a new signalling pathway behind macrophage inflammatory activity

Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.

Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders

An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments.